Advertisement

Wiener Medizinische Wochenschrift

, Volume 161, Issue 1–2, pp 6–12 | Cite as

Computergestütztes Patient-reported Outcome Monitoring in der Neuroonkologie: Lebensqualität und Rezidiv beim Glioblastom

  • Bernhard HolznerEmail author
  • Gabriele Schauer-Maurer
  • Guenter Stockhammer
  • Armin Muigg
  • Markus Hutterer
  • Johannes Giesinger
Themenschwerpunkt

Zusammenfassung

Zur wiederholten systematischen und prospektiven Aufzeichnung der subjektiven somatischen und psychosozialen Symptombelastung (patient related outcomes=PRO) wurde an der Medizinischen Universität Innsbruck das sogenannte "Computer-based Health Evaluation System" (CHES) implementiert. Diese Software dient der Sammlung, Speicherung und graphischen Aufbereitung von medizinischen und psychosozialen Daten in den verschiedensten Bereichen der Medizin (z. B. Onkologie, Geriatrie, Psychiatrie, Psychosomatik … ). Dieses Instrument konnte auch erfolgreich bei 34 Patienten mit rezidivierten malignen Gliomen eingesetzt werden und erwies sich bei insgesamt 185 Messungen (5,4 pro Patient) als zweckmäßig für den Einsatz in der Routinebetreuung von neuro-onkologischen PatientInnen.

Schlüsselwörter

Computer gestützte Aufzeichnung durch Patienten Lebensqualität Computer-Based Health Evaluation System – CHES EORTC QLQ30+ BN20 Maligne Gliome 

Patient reported outcome monitoring using a tablet PC is suitable for measuring quality of life in patients with gliomas

Summary

A computer-based tool for the monitoring of patient-related outcomes, the "Computer-based Health Evaluation System" (CHES) was developed at the medical university of Innsbruck. The software-generated graphic QOL profiles were found to be an important tool for screening patients for clinically relevant problems and were successfully used in oncology, geriatrics, psychiatry, and psychosomatics. The authors report their experience with CHES in 34 patients with recurrent gliomas. The computer-based QoL monitoring was repeated in median 5.4 times per patients and found feasible and well accepted by patients and personnel.

Keywords

Patient-reported outcome measures Quality of life Computer-Based Health Evaluation System – CHES EORTC QLQ30+ BN20 Malignant gliomas 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Wöhrer A, Waldhör T, Heinzl H, et al. The Austrian Brain Tumour Registry: a cooperative way to establish a population-based brain tumour registry. J Neurooncol, 95: 401–411, 2009CrossRefPubMedGoogle Scholar
  2. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med, 352: 987–996, 2005CrossRefPubMedGoogle Scholar
  3. Hart M, Grant R, Garside R, et al. Temozolomide for high grade glioma. Cochrane Database Syst Rev, 4: CD007415, 2008Google Scholar
  4. Taphoorn MJ, Stupp R, Coens C, et al. Health-related quality of life in patients with glioblastoma: a randomised controlled trial. Lancet Oncol, 6: 937–944, 2005CrossRefPubMedGoogle Scholar
  5. Bampoe J, Laperriere N, Pintilie M, et al. Quality of life in patients with glioblastoma multiforme participating in a randomized study of brachytherapy as a boost treatment. J Neurosurg, 93: 917–926, 2000CrossRefPubMedGoogle Scholar
  6. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst, 85: 365–376, 1993CrossRefPubMedGoogle Scholar
  7. Cella DF, Tulsky DS, Gray G, et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol, 11: 570–579, 1993PubMedGoogle Scholar
  8. Taphoorn M, Claassens L, Aaronson NK, et al. An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients. Eur J Cancer, 46: 1033–1040, 2010CrossRefPubMedGoogle Scholar
  9. Weitzner M, Meyers CA, Gelke CK, et al. The Functional Assessment of Cancer Therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors. Cancer, 75: 1151–1161, 1995CrossRefPubMedGoogle Scholar
  10. Casali P, Licitra L, Costantini M, et al. Quality of life assessment and clinical decision making. Ann Oncol, 8: 1207–1211, 1997CrossRefPubMedGoogle Scholar
  11. Buxton J, White M, Osoba D. Patients' experiences using a computerized program with a touch-sensitive video monitor for the assessment of health-related quality of life. Qual Life Res, 7: 513–519, 1998CrossRefPubMedGoogle Scholar
  12. Chang CH. Patient-reported outcomes measurement and management with innovative methodologies and technologies. Qual Life Res, 16(Suppl 1): 157–166, 2007CrossRefPubMedGoogle Scholar
  13. Detmar SB, Muller MJ, Schornagel JH, et al. Health-related quality-of-life assessments and patient-physician communication: a randomized controlled trial. JAMA, 228: 3027–3034, 2002CrossRefGoogle Scholar
  14. Wright EP, Selby PJ, Crawford M, et al. Feasibility and compliance of automated measurement of quality of life in oncology practice. J Clin Oncol, 21: 374–382, 2003CrossRefPubMedGoogle Scholar
  15. Evaluation Software Development, Computer-Based Health Evaluation System (CHES). Innsbruck, Austria, 2010Google Scholar
  16. Holzner B, Kemmler G, Cella D, et al. Normative data for functional assessment of cancer therapy – general scale and its use for the interpretation of quality of life scores in cancer survivors. Acta Oncol, 43: 153–160, 2004CrossRefPubMedGoogle Scholar
  17. Osoba D, Brada M, Prados MD, et al. Effect of disease burden on health-related quality of life in patients with malignant gliomas. Neuro Oncol, 2: 221–228, 2000PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Bernhard Holzner
    • 1
    Email author
  • Gabriele Schauer-Maurer
    • 1
  • Guenter Stockhammer
    • 2
  • Armin Muigg
    • 2
  • Markus Hutterer
    • 2
  • Johannes Giesinger
    • 1
  1. 1.Department für Psychiatrie und PsychotherapieMedizinische Universität InnsbruckInnsbruckAustria
  2. 2.Universitätsklinik für NeurologieMedizinische Universität InnsbruckInnsbruckAustria

Personalised recommendations